Cannabidiol, or CBD for short, is a phyto-cannabinoid found in cannabis plants. However, it does not cause the same psychoactive effects as other naturally occurring cannabinoids (such as tetrahydrocannabinol, or THC). CBD induces feelings of sleepiness and tranquility, making it suitable for insomnia and other sleep disorders; CBD can be used to alleviate symptoms of epilepsy, diabetes, and anxiety disorders, as well. Legality is an issue for some; all 50 states have laws governing the sale, possession, and use of CBD, and they vary significantly (see the table below for a full analysis).
Wyoming has a particularly narrow law for CBD oil. It is only legal for patients with epilepsy that has not responded to other treatments. Neurologists have to give the state's Department of Health a statement about how the patient needs and would benefit from the CBD, made from hemp extract, and then the patient may be able to receive a card that allows them to receive cannabis with high concentrations of CBD and trace amounts of THC.
Whereas Michigan already had medical weed legalized to make for a quicker route to starting full legislation, these states don't yet have an operational system in place. North Dakota and West Virginia also still are not operational yet, nor in Louisiana or Arkansas. Ohio is also behind schedule, having been unable to meet their goal of having operational dispensaries two years after voting for legalization. And until those are operational, the Ohio Board of Pharmacy ruled that any CBD products not sold in dispensaries licensed by the state's program are illegal.
Generalized pain, for instance, has dozens upon dozens of high profile research and clinical studies that have been carried out in universities and laboratories around the globe. One of the most well-publicized of these studies took place back in 2008, in which results determined that “cannabinoid analgesics (pain relievers) have generally been well tolerated in clinical trials … with acceptable adverse event profiles (meaning acceptable effectiveness for practical use).
“All parts of the plant Cannabis sativa L., whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resins; but shall not include the mature stalks of such plant fiber produced from such stalks oil or cake made from the seeds of such plant, any other compound, manufacture, salt, derivative, mixture, or preparation of such mature stalks (except the resin extracted therefrom),fiber, oil or cake, or the sterilized seed of such plant which is incapable of germination.”
This article provides a wealth of practical information for the individual considering CBD as an adjunctive or alternative treatment for pain and or anxiety. CBD works in the body by manipulating receptors throughout organ tissues, the immune system, the pain response system, the hormonal system, and other systemic regulatory systems. While CBD oils have not been reviewed or approved by the FDA for the treatment of these conditions, a wealth of literature, both anecdotal and research-related now exists to help describe both their safety and effectiveness. As discussed in this article, the potential new adopter must be mindful of several important items. First, only those products that are sourced from Industrial Hemp will be considered legal in all states. One must be careful if the product you choose is sourced from the marijuana plant, as those products may contain THC levels above the legal limit in your given state. Secondly, all products are NOT created equal – they differ significantly in strength, absorption, and elimination by the body and in the manner in which they are formulated. One should be mindful of the differences in doses available for each of these products, starting at a low or moderate dose and increasing as needed in order to find the lowest dose that provides the desired relief. In this way, one can individualize usage to maximize effectiveness, while minimizing risk, a proper goal for the use of all medicinals.
However, switching to CBD oil from a conventional medication is far from a random stab in the dark. In fact, there was a large scale (and very well-documented) survey carried out less than two years ago that looked at precisely what percentage of patients were able to “swap” their side effect-inducing meds for a 100% natural, cannabis-based therapy.
Our Best Value pick is CBDistillery, which offers a full spectrum CBD oil containing naturally occurring cannabinoids and terpenes, along with fatty acid Omega 3, B complex vitamins, and 20 essential amino acids. The oil is derived from non-GMO, U.S.-grown hemp. It also contains trace amounts of fractionated coconut oil for subtle flavoring. All product information and third-party testing results are found on the official CBDistillery product page.
Frankly, not many customers on amazon are dissatisfied with St. Mortiz Raw Hemp Extract Oil. Many customers state they’ve experienced noticeable results in the management of joint pain, sleeplessness, and depression and anxiety symptoms. Even when used as a simple health supplement with no health-related symptoms to treat, users have favored the taste and the results felt following the use of this product. Critical reviewers state that the oil simply didn’t work for them, but some still attest to hemp oil’s ability to help manage their health-related issues.
High-potency CBD oils are most suitable for people experiencing strong, insomnia, chronic aches and pains, anxiety/depression symptoms, and other conditions that necessitate stronger effects. Our top pick for this category is the Lab Grade CBD Oil from Spruce, which comes in a 30mL bottle with a concentration of 2,400mg. Each full dropper of oil contains roughly 80mg of CBD, which can be an effective dose for those with severe discomfort or symptoms.
As mentioned above, CBD is no longer considered a Schedule I controlled substance under the Farm Act. However, under the DEA’s definition, it remains on the list. This allows for individual states to create exceptions to the status of CBD, even when cultivated from hemp plants grown legally under the act. It also maintains illegal status for any CBD sourced from plants produced in settings that are not consistent with that Act, or by an unlicensed grower. It is expected that more clarification on the status of CBD will come early this year (2019).